@ProfessorZaius @mr_archenemy One reason, not the only one, is that other countries free-ride on US pharma R&D.
-
-
-
Replying to @mr_archenemy
@mr_archenemy@ProfessorZaius Hadn't seen it when I made comment.1 reply 0 retweets 0 likes -
Replying to @St_Rev
@St_Rev@mr_archenemy Got evidence on the free-riding claim?3 replies 0 retweets 0 likes -
Replying to @ProfessorZaius
@ProfessorZaius@mr_archenemy Pretty well-established IIRC. I think I read about it on In the Pipeline, McArdle has prob. written abt it too1 reply 0 retweets 0 likes -
Replying to @St_Rev
@St_Rev@mr_archenemy The US is close to UK and Germany in medical innovation per capita. http://download.pwc.com/ie/pubs/2011_medical_technology_innovation_scorecard_the_race_for_global_leadership_jan.pdf … http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1261198/?tool=pubmed …6 replies 0 retweets 0 likes -
Replying to @ProfessorZaius
@ProfessorZaius@mr_archenemy The free-riding comes from the regulatory price differentials--pharma can price in US to recapture R&D costs.1 reply 0 retweets 1 like -
Replying to @St_Rev
@St_Rev@mr_archenemy And British companies price higher in US too to recapture R&D. This seems like a subsidy from Americans to others.1 reply 0 retweets 0 likes -
Replying to @ProfessorZaius
@ProfessorZaius@mr_archenemy Yes, this is exactly the point. US patients subsidize the rest of the world's pharma research.1 reply 0 retweets 1 like -
Replying to @St_Rev
@St_Rev@mr_archenemy And you're arguing that this is a preferable state of affairs for US patients than an alternative in which they pay>4 replies 0 retweets 0 likes
@ProfessorZaius @mr_archenemy There are other baked-in problems, like cadillac-ization of hospitals, that single-payer won't fix.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
. Banned in Sweden. SubGenius, Zhuangist, white-hat troll. Defrocked mathematician. Brain problems.